A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT04819100 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04819100
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-20
- Primary completion
- 2026-01-12
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.